左心室のエジェクション分数と三弁の介入の利点 - 国際TRIGISTRYからの洞察
Gregor Heitzinger1, Julien Dreyfus2, Varius Dannenberg1
1Department of Internal Medicine II, Cardiology, Medical University of Vienna, Vienna, Austria.
European journal of heart failure
|August 31, 2025
まとめ
手術とトランスキャテータによる三弁介入 (TTVI) は,エジェクション分数保存 (pEF) TRを有する患者の生存率を改善します. しかし,軽度減少した (mrEF) または減少したエジェクション分数 (rEF) の患者では生存効果は認められなかった.
科学分野:
- 心臓病科
- 介入心臓科
- 心臓 外科
背景:
- トリコスピッド吐 (TR) の管理は,左心室噴出分数 (LVEF) に基づいて著しく異なります.
- LVEFスペクトルにおけるTRに対する介入と保守的な治療の比較効果はよく定義されていません.
研究 の 目的:
- 重度の単離型TR患者における三弁介入 (TTVI) と手術の結果を比較する.
- 保存された (pEF),軽く減少した (mrEF),および減少した (rEF) の異なるLVEFカテゴリーの生存効果を分析する.
主な方法:
- TRIGISTRYの国際レジストリデータ分析で,2384人の重症単発TR患者さんを対象とした.
- 患者はpEF (≥50%),mrEF (41-49%),rEF (≤40%) のグループに分類された.
- 2年生存率は,治療方法 (手術,TTVI,保守的) と処置の成功 (残留TR ≤中等) に基づいて評価された.
主要な成果:
- 手術とTTVIは,保守的な管理と比較して,pEF患者の生存効果を示した (p< 0. 0005とp< 0. 0001).
- mrEFまたはrEFのいずれかの介入で有意な生存の利点は見られなかった.
- TTVI後の残留TRは,すべてのLVEFカテゴリーで生存率の低下と関連していました.
結論:
- TTVIは,外科的および経導体の両方で,pEFを有するTR患者の生存を改善しますが,mrEFまたはrEFを有する患者の生存は改善しません.
- 残留TRはLVEFに関係なく重要な予後因子です.
- TTVIでは,特に LVEFが低下した患者では,慎重に選択することが重要です.
関連する概念動画
01:22Mitral Valve Prolapse II: Assessment and Management
39
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
39
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
37
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
37
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
57
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
57
01:25Mitral Regurgitation III: Medical Management
28
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
28
01:26Mitral Stenosis III: Medical Management
21
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
21
01:20Mitral Regurgitation I: Introduction
55
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
55